rediff.com

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  

Rediff News  All News 

Astellas Pharma

Rediff.com  »  News  »   Astellas Pharma

  News for Astellas Pharma

  • Business

Japanese pharma firm sets up Indian subsidiary

Astellas Pharma, the second largest Japanese drug company, has set up a wholly-owned subsidiary in India, making it the third Japanese pharma major after Daiichi Sankyo and Eisai to tap the growing......

Glenmark gets USFDA nod for skin infections cream

Glenmark Pharmaceuticals said on Monday it has received approval from the US health regulator for its generic Hydrocortisone Butyrate Cream used for treating variety of skin infections. Glenmark......

US stops launch of Dr Reddy's drug

Dr Reddy's Laboratories received a major setback in the US, as a court there granted a motion seeking a preliminary injunction to block the launch of its generic version of Sanofi-Aventis'......

Indian drug makers maintain pace of US mktg nod

Twenty five Indian generic drug makers got a little over 200 approvals from the US Food and Drug Administration in 2009, half a dozen more than the number approved in 2008.This increase is despite......

It's destination India for Japan Inc!

India has become the most sought destination for investment by Japanese companies, next to China, and ahead of other Asian countries and emerging economies like Russia, Brazil, Mexico and even the......
  Web results for Astellas Pharma
The International Bio-Community Meets in Japan!Announcing Integrated Biotech Business Event - BioJapan 2014

BioJapan 2014 World Business Forum will be held for three days from October 15th (Wed.) to 17th (Fri.), 2014 at Pacifico Yokohama (Exhibition... ...

http://businesswireindia.com/news/news-details/the-international-bio-community-meets-japanannouncing-integrated-biote/40483
Cancer Monoclonal Antibody Partnering Terms and Agreements

From the Wires Aug. 27, 2014 05:37 PM LONDON , Aug. 27, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:... ...

http://in.sys-con.com/node/3163524
Graft-Versus-Host Disease Treatment Market Worth $409.0m by 2018 Says a New Report Available at MarketOptimizer.org

MarketOptimizer.org adds OpportunityAnalyzer Graft-Versus-Host Disease Opportunity Analysis and Forecasts to 2018 to its store. The GVHD market... ...

http://www.bizwireexpress.com/showstoryPRWeb.php?storyid=278369
European Medicines Agency accepts Basilea's isavuconazole Marketing Authorization Application for review

Comments - LondonBasilea Pharmaceutica AG /European Medicines Agency accepts Basilea's isavuconazole Marketing Authorization Application for review... ...

http://andhranews.net/Business/2014/European-Medicines-Agency-accepts-Basileaaposs-isavuconazole-36219.htm
Veloxis Pharmaceuticals announces financial results for the first six months of 2014

the European Commission granted marketing authorization for EnvarsusĀ® for the prevention of organ rejection in adult kidney and liver transplant... ...

http://in.sys-con.com/node/3155310

Related Tags


  1. gujarat
  2. bjp
  3. india
  4. lok sabha
  5. supreme court
  6. upa
  7. bharatiya janata party
  8. congress
  9. new delhi
  10. united progressive alliance
  11. ahmedabad
  12. sonia gandhi
  13. nda
  14. rahul gandhi
  15. rajnath singh
  16. nitin gadkari
  17. delhi
  18. manmohan singh
  19. bihar
  20. national democratic alliance
  21. jd-u
  22. nitish kumar
  23. rashtriya swayamsevak sangh
  24. uttar pradesh
  25. photo
  26. advani
  27. central bureau of investigation
  28. rss
  29. janata dal-united
  30. ips

Related Pages


astellas pharma
Astellas Pharma

Company
0 Followers

Top Coverage News


Coming to India and making

Success in manufacturing is not just about being cheap - cheap labour, cheap land, cheap power...
Broswe by: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z